Stacy Enxing Seng

Stacy Enxing Seng has held a variety of positions in the past decade. In 2014, they began their work experience as a Director for Solace Therapeutics. Stacy then joined the Sonova Group as an Independent Director in the same year. In 2015, they became an Independent Director for Hill-Rom. In 2016, they began working as a Venture Partner for Lightstone Ventures. In 2017, they joined the Fogarty Institute for Innovation as an Independent Director. In 2018, they became an Independent Director for Precardia, Inc. In 2019, they became an Independent Director for LivaNova and Chairwoman of the Board, Independent Director for both Cala Health and Contego Medical, Inc. Most recently, in 2021, they were appointed as an Independent Director for Vesper Medical, Inc.

Stacy Enxing Seng obtained their Bachelor's Degree in Public Policy Analysis from Michigan State University between 1982 and 1986. Stacy then pursued a Master of Business Administration (M.B.A.) at Harvard Business School from 1991 to 1993. In 2016, they completed a Certificate of Completion from Stanford University Graduate School of Business in the field of Director's Consortium.